Search results for "Subgroup"

showing 10 items of 237 documents

Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study

2013

Results 67 of the 96 female patients of the intention-to-treat population of the main study had regular menstrual cycles and were thus included in this subgroup analysis. 77 migraine attacks classified as related to menses were treated with frovatriptan and 78 with almotriptan. Rate of pain relief at 2and 4-hrs was 36% and 53% for frovatriptan and 41% and 50% for almotriptan (p=NS between treatments). Rate of pain free at 2and 4-hrs was 19% and 47% with frovatriptan and 29% and 54% for almotriptan (p=NS). At 24-hrs, 62% of frovatriptanand 67% of almotriptan-treated patients had pain relief, while 60% vs. 67% were pain free (p=NS). Recurrence at 24-hrs was significantly (p<0.05) lower with f…

medicine.medical_specialtyeducation.field_of_studyTraditional medicinebusiness.industrymedia_common.quotation_subjectPopulationPain reliefClinical NeurologySubgroup analysisGeneral Medicinemedicine.diseaseAnesthesiology and Pain MedicineMigraineInternal medicineAlmotriptanFemale patientPoster PresentationmedicineNeurology (clinical)FrovatriptaneducationbusinessMenstrual cyclemedicine.drugmedia_commonThe Journal of Headache and Pain
researchProduct

Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis

2018

AbstractWe conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27th, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849…

medicine.medical_specialtylcsh:MedicineSubgroup analysisRisk AssessmentArticle03 medical and health sciences0302 clinical medicinemild cognitive impairmentInternal medicineMedicineDementiaHumansCognitive Dysfunction030212 general & internal medicineCognitive declineProspective cohort studyVascular dementialcsh:ScienceMultidisciplinarybusiness.industrylcsh:RStatinInibidores de Hidroximetilglutaril-CoA Redutasesmedicine.diseaseRelative riskMeta-analysislcsh:QDementiaHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessRisk assessment030217 neurology & neurosurgerydementiaDemência
researchProduct

An FFR CT diagnostic strategy versus usual care in patients with suspected coronary artery disease planned for invasive coronary angiography at Germa…

2017

Aim Diagnostic evaluation practices for suspected coronary artery disease (CAD) may vary between countries. Our objective was to compare a CT-derived fractional flow reserve (FFRCT) diagnostic strategy with usual care in patients with planned invasive coronary angiography (ICA) enrolled in the PLATFORM (Prospective Longitudinal Trial of FFRCT: Outcome and Resource Impacts) study at German sites. Methods Patients were divided into two consecutive observational cohorts, receiving either usual care or CT angiography (CTA)/FFRCT. The primary endpoint was the percentage of patients planned for ICA, with no obstructive CAD on ICA within 90 days. Secondary endpoints included death, myocardial infa…

medicine.medical_specialtymedicine.diagnostic_testUnstable anginabusiness.industrySubgroup analysisFractional flow reserve030204 cardiovascular system & hematologymedicine.diseaseSurgeryCoronary artery disease03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineAngiographymedicineClinical endpoint030212 general & internal medicineMyocardial infarctionCardiology and Cardiovascular MedicinebusinessOpen Heart
researchProduct

AB0210 Quality of Life Indexes in Patients with Very Early Rheumatoid Arthritis (VERA): A Two Center Subgroup Analysis from The Adapthera Cohort: Tab…

2016

Background The significance of early diagnosis and early therapy initiation in patients with RA is tremendous. ADAPTHERA is a state wide rheumatology network based in Rhineland-Palatinate, Germany. ADAPTHERA aims to improve RA prognosis and quality of patients` life by reducing the time-to-RA-diagnosis. While there have been a lot of studies regarding quality of life in patients with established RA 1,2 , adequate data concerning very early rheumatoid arthritis (VERA) (disease duration Objectives To study quality of life in VERA patients and to investigate its associations with various RA associated clinical and laboratory parameters. Methods In a two center subgroup analysis from the ADAPTH…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryVisual analogue scaleImmunologySubgroup analysisGeneral Biochemistry Genetics and Molecular BiologyRheumatologyRheumatologyQuality of lifeInternal medicineErythrocyte sedimentation rateCohortmedicinePhysical therapyImmunology and AllergyRheumatoid factorFunctional abilitybusinessAnnals of the Rheumatic Diseases
researchProduct

Palliative splenic irradiation in primary and post PV/ET myelofibrosis: outcomes and toxicity of three radiation schedules

2009

Splenectomy and splenic irradiation (SI) are the sole treatment modalities to control drug resistant splenomegaly in patients with myelofibrosis (MF). SI has been used in poor surgical candidates but optimal total dose and fractionation are unclear. We retrospectively reviewed 14 MF patients with symptomatic splenomegaly. Patients received a median of 10 fractions in two weeks. Fraction size ranged from 0.2–1.4 Gy, and total dose varied from 2–10.8 Gy per RT course. Overall results indicate that 81.8% of radiation courses achieved a significant spleen reduction. Splenic pain relief and gastrointestinal symptoms reduction were obtained in 94% and 91% of courses, respectively. Severe cytopeni…

medicine.medical_specialtypalliationmedicine.medical_treatmentSplenectomyMyelofibrosisSpleenSubgroup analysisGastroenterologyArticleInternal medicineMedicinemyelofibrosis; splenomegaly; palliation; radiotherapy; low-dose irradiationMyelofibrosisAdverse effectradiotherapylow dose irradiationsplenomegalylcsh:RC633-647.5business.industrylow-dose irradiation.lcsh:Diseases of the blood and blood-forming organsHematologymedicine.diseaseSurgeryRadiation therapymedicine.anatomical_structureTolerabilityToxicitybusinessHematology Reports
researchProduct

Abelian Sylow subgroups in a finite group, II

2015

Abstract Let p ≠ 3 , 5 be a prime. We prove that Sylow p-subgroups of a finite group G are abelian if and only if the class sizes of the p-elements of G are all coprime to p. This gives a solution to a problem posed by R. Brauer in 1956 (for p ≠ 3 , 5 ).

p-groupCombinatoricsMathematics::Group TheoryNormal p-complementAlgebra and Number TheoryLocally finite groupSylow theoremsCyclic groupElementary abelian groupOmega and agemo subgroupAbelian groupMathematicsJournal of Algebra
researchProduct

ON SYLOW NORMALIZERS OF FINITE GROUPS

2013

[EN] The paper considers the influence of Sylow normalizers, i.e. normalizers of Sylow subgroups, on the structure of finite groups. In the universe of finite soluble groups it is known that classes of groups with nilpotent Hall subgroups for given sets of primes are exactly the subgroup- closed saturated formations satisfying the following property: a group belongs to the class if and only if its Sylow normalizers do so. The paper analyzes the extension of this research to the universe of all finite groups.

p-groupComplement (group theory)Finite groupAlgebra and Number TheorySaturated formationApplied MathematicsSylow theoremsNilpotent Hall subgroupAlgebraMathematics::Group TheorySylow normalizerIUMPALocally finite groupFinite groupAlgebra over a fieldScientific publishingMATEMATICA APLICADAMathematicsJournal of Algebra and Its Applications
researchProduct

On second minimal subgroups of Sylow subgroups of finite groups

2011

A subgroup H of a finite group G is a partial CAP-subgroup of G if there is a chief series of G such that H either covers or avoids its chief factors. Partial cover and avoidance property has turned out to be very useful to clear up the group structure. In this paper, finite groups in which the second minimal subgroups of their Sylow p-subgroups, p a fixed prime, are partial CAP-subgroups are completely classified.

p-groupComplement (group theory)Finite groupAlgebra and Number TheorySupersoluble groupSylow theoremsCombinatoricsNormal p-complementMathematics::Group TheorySecond minimal subgroupLocally finite groupSimple groupOmega and agemo subgroupFinite groupMATEMATICA APLICADAMathematicsPartial CAP-subgroupPartial cap-group
researchProduct

The average number of Sylow subgroups of a finite group

2013

We prove that if the average Sylow number (ignoring the Sylow numbers that are one) of a finite group G is ⩽7, then G is solvable.

p-groupDiscrete mathematicsFinite groupComplement (group theory)General MathematicsSylow theoremsMathematics::Algebraic TopologyHall subgroupCombinatoricsMathematics::Group TheoryNormal p-complementLocally finite groupComponent (group theory)MathematicsMathematische Nachrichten
researchProduct

The Fitting Subgroup and Some Injectors of Radical Locally Finite Groups with min-pfor Allp

2003

Abstract This work was intended as an attempt to continue the study of the class ℬ of generalised nilpotent groups started in a previous paper. We present some results concerning the Fitting subgroup and the ℬ-injectors of a radical locally finite group satisfying min-p for all p.

p-groupDiscrete mathematicsPure mathematicsNilpotentAlgebra and Number TheoryLocally finite groupExtra special groupCA-groupNilpotent groupCentral seriesFitting subgroupMathematicsCommunications in Algebra
researchProduct